Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 5, 2021

View Archived Issues

Modulating PPM1E is a therapeutic approach in type 2 diabetes

Genentech patents new TEAD inhibitors

E-Scape Bio discloses LRRK2 inhibitors

University of Kentucky identifies histone demethylase and Wnt signaling inhibitors

Janpix divulges new STAT5 inhibitors

Fochon Pharmaceuticals synthesizes new BTK inhibitors

Microbiome therapy SER-155 may restore colonization resistance and prevent infection

JSF-3151 demonstrates efficacy in mouse model of MRSA infection

Selecta and Takeda enter strategic licensing agreement for lysosomal storage disorders

OncoTherapy Science presents data on OTSA-101 in cervical cancer mouse model

Targeting ADGRF1 for obesity and associated metabolic diseases

Protein mimetic amyloid inhibitor shows antitumor activity in vivo

KRP-A218, an oral PI4KB inhibitor, is a potent antiviral in vivo

Taysha collaborates with UTSW on next-generation construct for the treatment of CLN7 disease

New model provides insight into tau propagation in early Alzheimer's disease

Depression's doldrums linked to diagnostic duality at ECNP

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...